2024 Q2 Form 10-Q Financial Statement

#000081555624000019 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.916B $1.895B
YoY Change 1.76% 1.94%
Cost Of Revenue $1.053B $1.034B
YoY Change 2.64% 2.42%
Gross Profit $863.5M $861.6M
YoY Change 0.7% 1.36%
Gross Profit Margin 45.06% 45.46%
Selling, General & Admin $476.6M $471.4M
YoY Change 3.03% 3.2%
% of Gross Profit 55.19% 54.71%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $43.70M $40.20M
YoY Change -2.67% -9.66%
% of Gross Profit 5.06% 4.67%
Operating Expenses $476.6M $471.4M
YoY Change 3.03% 3.2%
Operating Profit $386.9M $390.2M
YoY Change -2.03% -0.76%
Interest Expense -$500.0K $2.000M
YoY Change -78.26% -157.14%
% of Operating Profit -0.13% 0.51%
Other Income/Expense, Net
YoY Change
Pretax Income $386.4M $389.8M
YoY Change -1.58% 0.03%
Income Tax $93.70M $92.10M
% Of Pretax Income 24.25% 23.63%
Net Earnings $292.7M $297.7M
YoY Change -1.78% 0.88%
Net Earnings / Revenue 15.28% 15.71%
Basic Earnings Per Share $0.51 $0.52
Diluted Earnings Per Share $0.51 $0.52
COMMON SHARES
Basic Shares Outstanding 572.5M shares 572.2M shares
Diluted Shares Outstanding 574.1M shares 574.1M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $255.5M $237.1M
YoY Change 4.89% -1.13%
Cash & Equivalents $255.5M $237.1M
Short-Term Investments
Other Short-Term Assets $181.8M $136.9M
YoY Change 16.24% 14.08%
Inventory $1.505B $1.496B
Prepaid Expenses
Receivables $1.205B $1.213B
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.147B $3.084B
YoY Change 0.31% -2.47%
LONG-TERM ASSETS
Property, Plant & Equipment $1.301B $1.013B
YoY Change 2.14% -18.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $155.5M $158.1M
YoY Change -6.21% -6.0%
Total Long-Term Assets $1.457B $1.449B
YoY Change 1.18% 2.38%
TOTAL ASSETS
Total Short-Term Assets $3.147B $3.084B
Total Long-Term Assets $1.457B $1.449B
Total Assets $4.604B $4.533B
YoY Change 0.58% -0.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $292.6M $276.0M
YoY Change 11.68% 3.45%
Accrued Expenses $314.4M $207.5M
YoY Change -3.14% -35.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $110.0M $0.00
YoY Change -26.67% -100.0%
Total Short-Term Liabilities $717.0M $637.9M
YoY Change -2.66% -26.1%
LONG-TERM LIABILITIES
Long-Term Debt $125.0M $200.0M
YoY Change -37.5% 0.0%
Other Long-Term Liabilities $191.7M $5.800M
YoY Change 9.48% -96.36%
Total Long-Term Liabilities $316.7M $205.8M
YoY Change -15.57% -42.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $717.0M $637.9M
Total Long-Term Liabilities $316.7M $205.8M
Total Liabilities $1.108B $843.7M
YoY Change -7.37% -35.42%
SHAREHOLDERS EQUITY
Retained Earnings $3.501B $3.431B
YoY Change 2.6% 3.54%
Common Stock $69.30M $64.50M
YoY Change 170.7% 277.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.496B $3.429B
YoY Change
Total Liabilities & Shareholders Equity $4.604B $4.533B
YoY Change 0.58% -0.97%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $292.7M $297.7M
YoY Change -1.78% 0.88%
Depreciation, Depletion And Amortization $43.70M $40.20M
YoY Change -2.67% -9.66%
Cash From Operating Activities $258.0M $335.6M
YoY Change -14.6% -13.62%
INVESTING ACTIVITIES
Capital Expenditures $56.10M $50.80M
YoY Change 0.36% 50.74%
Acquisitions
YoY Change
Other Investing Activities $3.400M $100.0K
YoY Change 100.0% -96.3%
Cash From Investing Activities -$52.70M -$48.40M
YoY Change -2.77% 56.13%
FINANCING ACTIVITIES
Cash Dividend Paid $223.3M $223.2M
YoY Change 11.71% 11.71%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $190.0M $220.0M
YoY Change -58.24% -42.86%
Cash From Financing Activities -185.5M -$267.4M
YoY Change -23.76% -23.36%
NET CHANGE
Cash From Operating Activities 258.0M $335.6M
Cash From Investing Activities -52.70M -$48.40M
Cash From Financing Activities -185.5M -$267.4M
Net Change In Cash 19.80M $15.80M
YoY Change 330.43% 83.72%
FREE CASH FLOW
Cash From Operating Activities $258.0M $335.6M
Capital Expenditures $56.10M $50.80M
Free Cash Flow $201.9M $284.8M
YoY Change -17.99% -19.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
637900000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
661300000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
200000000.0 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
200000000.0 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
186000000.0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
178800000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
73800000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
73000000.0 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5800000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1000000.0 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
5700000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5700000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
861600000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
850000000.0 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
471400000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
456800000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
390200000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
393200000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
1600000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
572300000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
570900000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
574100000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
572600000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
297700000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295100000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0.0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0.0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11900000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4300000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
285800000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
299400000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.35
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
57000000.0 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
571982367 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
571982367 shares
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
58800000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
41000000.0 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3431400000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3356900000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-66700000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-54800000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3429200000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3348800000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4532700000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4462900000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
400000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
2000000.0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
3900000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
389800000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
389700000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
92100000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
94600000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
297700000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295100000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3429200000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3270600000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.39
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.35
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
297700000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295100000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
40200000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
41800000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
600000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
600000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-900000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1400000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
800000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
300000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2000000.0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1900000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2700000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2700000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
127600000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
133700000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-21900000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-57700000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-34900000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-45400000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15600000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8500000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-31900000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11900000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
74500000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
83900000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-6300000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1200000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
335600000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
388500000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50800000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33700000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2500000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2800000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
100000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
100000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48400000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31000000.0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
160000000.0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
230000000.0 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
220000000.0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
385000000.0 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15800000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5900000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
223200000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
199800000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-267400000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-348900000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4000000.0 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1100000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15800000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9700000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221300000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230100000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237100000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
239800000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
2400000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
5100000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15900000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9700000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
30400000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
25900000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1895100000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1859100000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.39
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.35
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.35
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.35
CY2023Q4 fast Common Stock Special Dividends Per Share Cash Paid
CommonStockSpecialDividendsPerShareCashPaid
0.38
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
11655824 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5177879 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2520144 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P8Y
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2000000.0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1900000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
24800000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y7M13D
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
260000000.0 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
572339493 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
570928848 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1751214 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1703741 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
574090707 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
572632589 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
958569 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2269908 shares
CY2024Q1 fast Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice
63.55
CY2023Q1 fast Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice
52.17
CY2024Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 usd
CY2024Q1 us-gaap Residual Value Of Leased Asset
ResidualValueOfLeasedAsset
125800000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
200000000.0 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
60000000.0 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
200000000.0 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
200000000.0 usd
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000815556-24-000019-index-headers.html Edgar Link pending
0000815556-24-000019-index.html Edgar Link pending
0000815556-24-000019.txt Edgar Link pending
0000815556-24-000019-xbrl.zip Edgar Link pending
fast-20240331.htm Edgar Link pending
fast-20240331.xsd Edgar Link pending
fast03312024ex_31.htm Edgar Link pending
fast03312024ex_32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
fast-20240331_cal.xml Edgar Link unprocessable
fast-20240331_def.xml Edgar Link unprocessable
fast-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
fast-20240331_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fast-20240331_pre.xml Edgar Link unprocessable